126 related articles for article (PubMed ID: 15225859)
1. Comparative in vitro activity of antiribosomal agents on penicillin-susceptible and -resistant Streptococcus pneumoniae in relation to their resistance genotypes.
Sener B; Köseoglu O
Int J Antimicrob Agents; 2004 Jul; 24(1):39-42. PubMed ID: 15225859
[TBL] [Abstract][Full Text] [Related]
2. Serotypes, Clones, and Mechanisms of Resistance of Erythromycin-Resistant Streptococcus pneumoniae Isolates Collected in Spain.
Calatayud L; Ardanuy C; Cercenado E; Fenoll A; Bouza E; Pallares R; Martín R; Liñares J
Antimicrob Agents Chemother; 2007 Sep; 51(9):3240-6. PubMed ID: 17606677
[TBL] [Abstract][Full Text] [Related]
3. [Differentiation of resistance phenotypes among erythromycin-resistant streptococci].
Bejuk D
Acta Med Croatica; 2004; 58(4):301-6. PubMed ID: 15700686
[TBL] [Abstract][Full Text] [Related]
4. [Streptococcus pneumoniae strains resistance to macrolide, lincosamide, streptogramin, oxazolidinone and ketolide].
Sener B; Köseoğlu O; Fişenk I; Hasçelik G; Günalp A
Mikrobiyol Bul; 2002 Apr; 36(2):125-31. PubMed ID: 12652863
[TBL] [Abstract][Full Text] [Related]
5. Activities of 16-membered ring macrolides and telithromycin against different genotypes of erythromycin-susceptible and erythromycin-resistant Streptococcus pyogenes and Streptococcus pneumoniae.
Mazzariol A; Koncan R; Vitali LA; Cornaglia G
J Antimicrob Chemother; 2007 Jun; 59(6):1171-6. PubMed ID: 17405779
[TBL] [Abstract][Full Text] [Related]
6. In vitro antibacterial activity of beta-lactams and non-beta-lactams against Streptococcus pneumoniae isolates from Sydney, Australia.
Gosbell IB; Fernandes LA; Fernandes CJ
Pathology; 2006 Aug; 38(4):343-8. PubMed ID: 16916725
[TBL] [Abstract][Full Text] [Related]
7. Characterization of erythromycin-resistant Streptococcus pneumoniae in Korea, and In Vitro activity of telithromycin against erythromycin-resistant Streptococcus pneumoniae.
Kim NJ; Park SJ; Choi SH; Lee MS; Choo EJ; Kwak YG; Woo JH; Ryu J; Jeong JY; Kim YS
Microb Drug Resist; 2005; 11(3):260-5. PubMed ID: 16201929
[TBL] [Abstract][Full Text] [Related]
8. Phenotypic and genotypic characterization of macrolide resistant Streptococcus pneumoniae in Tunisia.
Rachdi M; Boutiba-Ben Boubaker I; Moalla S; Smaoui H; Hammami A; Kechrid A; Ben Redjeb S
Pathol Biol (Paris); 2008 May; 56(3):125-9. PubMed ID: 17604572
[TBL] [Abstract][Full Text] [Related]
9. Genotypes of macrolide-resistant pneumococci from children in southwestern Japan: raised incidence of strains that have both erm(B) and mef(A) with serotype 6B clones.
Ikenaga M; Kosowska-Shick K; Gotoh K; Hidaka H; Koga H; Masunaga K; Nagai K; Tsumura N; Appelbaum PC; Matsuishi T
Diagn Microbiol Infect Dis; 2008 Sep; 62(1):16-22. PubMed ID: 18068325
[TBL] [Abstract][Full Text] [Related]
10. Macrolide resistance mechanisms among Streptococcus pneumoniae isolated over 6 years of Canadian Respiratory Organism Susceptibility Study (CROSS) (1998 2004).
Wierzbowski AK; Nichol K; Laing N; Hisanaga T; Nikulin A; Karlowsky JA; Hoban DJ; Zhanel GG
J Antimicrob Chemother; 2007 Oct; 60(4):733-40. PubMed ID: 17673477
[TBL] [Abstract][Full Text] [Related]
11. Macrolide resistance mechanisms and in vitro susceptibility patterns of viridans group streptococci isolated from blood cultures.
Ergin A; Ercis S; Hasçelik G
J Antimicrob Chemother; 2006 Jan; 57(1):139-41. PubMed ID: 16291867
[TBL] [Abstract][Full Text] [Related]
12. Mechanisms of macrolide resistance in clinical pneumococcal isolates in a university hospital, Ankara, Turkey.
Sener B; Köseoglu O; Gür D; Bryskier A
J Chemother; 2005 Feb; 17(1):31-5. PubMed ID: 15828441
[TBL] [Abstract][Full Text] [Related]
13. Antimicrobial susceptibility patterns and macrolide resistance genes of viridans group streptococci from blood cultures in Korea.
Uh Y; Shin DH; Jang IH; Hwang GY; Lee MK; Yoon KJ; Kim HY
J Antimicrob Chemother; 2004 Jun; 53(6):1095-7. PubMed ID: 15117924
[TBL] [Abstract][Full Text] [Related]
14. Macrolide resistance in Streptococcus pneumoniae in Hong Kong.
Ip M; Lyon DJ; Yung RW; Chan C; Cheng AF
Antimicrob Agents Chemother; 2001 May; 45(5):1578-80. PubMed ID: 11302833
[TBL] [Abstract][Full Text] [Related]
15. Pharmacodynamic activity of azithromycin against macrolide-susceptible and -resistant Streptococcus pneumoniae simulating clinically achievable free serum, epithelial lining fluid and middle ear fluid concentrations.
Zhanel GG; DeCorby M; Noreddin A; Mendoza C; Cumming A; Nichol K; Wierzbowski A; Hoban DJ
J Antimicrob Chemother; 2003 Jul; 52(1):83-8. PubMed ID: 12775677
[TBL] [Abstract][Full Text] [Related]
16. [Phenotypic characterization of erythromycin resistance in strains of the genus Streptococcus isolated from clinical specimens].
Limia A; Jiménez ML; Delgado T; Sánchez I; López S; López-Brea M
Rev Esp Quimioter; 1998 Sep; 11(3):216-20. PubMed ID: 9795307
[TBL] [Abstract][Full Text] [Related]
17. Comparison of the in vitro activity of pristinamycin and quinupristin/dalfopristin against Streptococcus pneumoniae.
Lozniewski A; Lion C; Mory F; Weber M
Pathol Biol (Paris); 2000 Jun; 48(5):463-6. PubMed ID: 10949841
[TBL] [Abstract][Full Text] [Related]
18. Susceptibilities of Streptococcus pyogenes and Streptococcus pneumoniae to macrolides and telithromycin: data from an Italian multicenter study.
Mazzariol A; Koncan R; Bahar G; Cornaglia G
J Chemother; 2007 Oct; 19(5):500-7. PubMed ID: 18073148
[TBL] [Abstract][Full Text] [Related]
19. [Characterization of macrolide-resistance mediated by transposable elements Tn1545 and Tn917 in clinical Isolates of Streptococcus pneumoniae].
Wu WJ; Hong XH; Zhang H; Jiang YQ; Lu Q; Ni YX
Zhonghua Yi Xue Za Zhi; 2006 Mar; 86(9):605-8. PubMed ID: 16681905
[TBL] [Abstract][Full Text] [Related]
20. In vitro activity of six macrolides, clindamycin and tetracycline on Streptococcus pneumoniae with different penicillin susceptibilities.
Poulsen RL; Knudsen JD; Petersen MB; Fuursted K; Espersen F; Frimodt-Møller N
APMIS; 1996 Mar; 104(3):227-33. PubMed ID: 8611198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
